146 related articles for article (PubMed ID: 30373389)
1. A rapid and sensitive fluorescence method for detecting urine formaldehyde in patients with Alzheimer's disease.
Ai L; Wang J; Li T; Zhao C; Tang Y; Wang W; Zhao S; Jiang W; Di Y; Fei X; Luo H; Li H; Luo W; Yu Y; Lin W; He R; Tong Z
Ann Clin Biochem; 2019 Mar; 56(2):210-218. PubMed ID: 30373389
[TBL] [Abstract][Full Text] [Related]
2. Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.
Tong Z; Wang W; Luo W; Lv J; Li H; Luo H; Jia J; He R
J Alzheimers Dis; 2017; 55(3):1031-1038. PubMed ID: 27802225
[TBL] [Abstract][Full Text] [Related]
3. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
[TBL] [Abstract][Full Text] [Related]
4. A rapid and non-invasive fluorescence method for quantifying coenzyme Q10 in blood and urine in clinical analysis.
Fei X; Yu Y; Di Y; Ai L; Yao D; Bai S; Zhao S; Lyu J; Cai X; He R; Tong Z
J Clin Lab Anal; 2020 Apr; 34(4):e23130. PubMed ID: 31876061
[TBL] [Abstract][Full Text] [Related]
5. A Sensitive and Rapid Method for Detecting Formaldehyde in Brain Tissues.
Yue X; Zhang Y; Xing W; Chen Y; Mu C; Miao Z; Ge P; Li T; He R; Tong Z
Anal Cell Pathol (Amst); 2017; 2017():9043134. PubMed ID: 29147638
[TBL] [Abstract][Full Text] [Related]
6. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
[TBL] [Abstract][Full Text] [Related]
7. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
8. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel derivatization method for the determination of lactate in urine and saliva by liquid chromatography with UV and fluorescence detection.
Pellegrini D; Onor M; Degano I; Bramanti E
Talanta; 2014 Dec; 130():280-7. PubMed ID: 25159410
[TBL] [Abstract][Full Text] [Related]
10. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of catecholamines and their metabolites related to Alzheimer's disease in human urine.
Liu L; Li Q; Li N; Ling J; Liu R; Wang Y; Sun L; Chen XH; Bi K
J Sep Sci; 2011 May; 34(10):1198-204. PubMed ID: 21462336
[TBL] [Abstract][Full Text] [Related]
12. A high selectivity and sensitivity analytical method for the analysis of 8-hydroxy-2'-deoxyguanosine in the urine of Alzheimer's disease patients.
Lian K; Zhang P; Niu L; Jiang L; Kang W
Clin Chem Lab Med; 2015 Jun; 53(7):e165-8. PubMed ID: 25581760
[No Abstract] [Full Text] [Related]
13. [Planning and activities of daily living in Alzheimer's disease and frontotemporal dementia].
Piquard A; Derouesné C; Lacomblez L; Siéroff E
Psychol Neuropsychiatr Vieil; 2004 Jun; 2(2):147-56. PubMed ID: 15683978
[TBL] [Abstract][Full Text] [Related]
14. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between arterial pressure and cognitive functions. Data for the French Network on Alzheimer's disease (REAL.FR)].
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS
Rev Med Interne; 2003 Oct; 24 Suppl 3():292s-300s. PubMed ID: 14710447
[TBL] [Abstract][Full Text] [Related]
16. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
[TBL] [Abstract][Full Text] [Related]
17. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease.
Byrne LM; Wilson PM; Bucks RS; Hughes AO; Wilcock GK
Int J Geriatr Psychiatry; 2000 Jul; 15(7):656-61. PubMed ID: 10918348
[TBL] [Abstract][Full Text] [Related]
19. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
20. Determination of formaldehyde in urine by headspace gas chromatography.
Takeuchi A; Takigawa T; Abe M; Kawai T; Endo Y; Yasugi T; Endo G; Ogino K
Bull Environ Contam Toxicol; 2007 Jul; 79(1):1-4. PubMed ID: 17618393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
